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SUMMARY Pseudoepitheliomatous hyperplasia (PEH) is a 
benign, reactive epithelial proliferation. PEH is characterized 
by hyperplasia of the epidermis or adnexal epithelium into 
irregular squamous strands that extend deep down into the 
subjacent dermis. PEH occurs in response to underlying 
infections, inflammatory or neoplastic conditions. The presence 
of PEH overlying cutaneous melanoma is rare. The clinical and 
histological features of PEH can closely mimic squamous cell 
carcinoma and could be misinterpreted. We report two cases of 
cutaneous primary melanoma associated with PEH and discuss 
differential diagnoses and potential role of p53 and bcl-2 in the 
pathogenesis of PEH.
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INTRODUCTION
 Pseudoepitheliomatous hyperplasia (PEH), 
also known as pseudocarcinomatous hyperplasia, 
is a benign pathological reaction pattern (1). PEH 
occurs in response to persistent inflammation of 
the subjacent dermis due to a chronic wound, 
retained foreign material or an infection (fungal, 
bacterial or viral) (2). Reactive, exuberant epithe-
lial proliferation is also seen in coexistence with 
some dermatological conditions such as prurigo 
nodularis, granuloma fissuratum, chondrodermati-
tis nodularis, lichen planus and lichen sclerosus of 
the vulva (3,4). Tumors with overlying PEH include 
granular cell tumor, cutaneous T cell lymphomas, 
and salivary gland pleomorphic adenoma (5-7). 
The association of PEH with benign melanocytic 
nevi and Spitz nevi is not uncommon and is well 
documented in the literature (8,9). However, re-
ports documenting the association of PEH with 
melanoma are rare. In fact, little is known about 
the pathogenesis of PEH, regardless of the under-
lying etiology. We report two cases of cutaneous 
primary melanoma associated with histological 
features of PEH mimicking squamous cell carci-
noma.
CASE REPORTS
 The first patient was a 38-year-old male that 
presented with a polypoid, grayish-brown skin tu-
mor on the left thigh measuring 1.5 cm in largest 
diameter. The second patient was a 75-year-old 
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female with elevated, brownish tumor on the face, 
measuring 0.8 cm in largest diameter. Clinically, in 
both cases hyperkeratotic skin lesions were sus-
pected for squamous cell carcinoma. Histopatho-
logic analysis of excised lesions revealed abnor-
mal architectural and cytological features on he-
matoxylin and eosin (H&E) stained slides, which 
were indicative of malignant melanoma, classifed 
as Breslow III in the first case and Breslow V in the 
second case.  
 In each case, prominent hyperkeratosis, epi-
dermal acanthosis with irregular cords of well-
differentiated epithelial cells extending into the 
dermis and infiltrating among and around the 
melanoma cells, and multiple horn cysts was ob-
served. The hyperplastic foci arose directly from 
the epidermis without association with adnexal 
epithelium. In both cases, admixture of the neo-
plastic melanocytic and hyperplastic keratinocytic 
components led us to reconsider the diagnosis 
of malignant melanoma and concurrent invasive 
squamous cell carcinoma. Serial sectioning us-
ing immunohistochemical analysis of HMB-45 and 
cytokeratin (DAKO, Copenhagen, Denmark) was 
performed (Fig. 1A, B). On immunohistochemical 
slides, the neoplastic melanocytic component was 
easier to identify and distinguish from the hyper-
plastic epidermal component, and the possibility 
of squamous cell carcinoma was excluded. 
 Additionally, in each case immunohistochemi-
cal analysis of p53 and bcl-2 (DAKO) was per-
formed. In each patient, 4-μm sections were cut, 
slides were stained immunohistochemically by the 
labeled streptavidin biotin method (LSAB) as visu-
alization system on Dako Tech Mate automated 
immunostainer using microwave streptavidin im-
munoperoxidase (MSIP) protocol. Staining in-
tensity in the hyperplastic superficial epithelium, 
strands of proliferative epithelium and epithelium 
of horn cysts was compared with melanoma cells 
and adjacent basal epidermal cells (Fig. 2A, B). 
The intensity of immunostaining was semi-quan-
titatively scored and defined as: 0 (negative); 1+ 
(week staining, similar to adjacent normal basal 
epithelium); 2+ (moderate staining, less intense 
than in atypical melanoma cells); and 3+ (strong 
staining, equivalent to atypical melanoma cells). 
Results are summarized in Table 1. 
Table 1. p53 and bcl-2 immunohistochemical staining in two cases of pseudoepitheliomatous hyperplasia 
overlying primary cutaneous melanoma





















0, negative reaction; +, week staining, similar to adjacent normal basal epithelium; ++, moderate staining, less 
intense than in atypical melanoma cells; +++, strong staining, equivalent to atypical melanoma cells
Figure 1A. Epithelial strands with horn cysts 
originating from the epidermis and infiltrating 
the dermis among and around melanoma cells. 
(CK, x100)
Figure 1B. Admixture of neoplastic melanocytic 
and hyperplastic keratinocytic cells in the dermis. 
(HMB-45, x200)
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DISCUSSION
 PEH may mimic well differentiated, infiltrat-
ing squamous cell carcinoma or complicate the 
diagnosis of melanoma obscuring the underlying 
malignant process, thus leading to inappropriate 
diagnosis and treatment. In the differential diag-
nosis of atypical pigmented lesion, melanoma as-
sociated with PEH can be confused with rare pig-
mented squamous cell carcinoma of the skin (10). 
Unlike squamous cell carcinoma, PEH never has 
atypical mitotic figures, rarely has dyskeratosis or 
atypical nuclei, and is never involved in vascular, 
lymphatic or perineural invasion (11).
 In the literature, there are some articles that 
report on PEH overlying cutaneous melanoma. 
Kamino et al. have reported four cases, each case 
revealing hyperplasia of the epidermis and of up-
per portion of adnexal epithelium with squamous 
eddies and horn cysts (12). A case of PEH with 
thin cords of well differentiated epithelial cells per-
colating the melanoma cells originating only from 
the epidermis, without evidence of adnexal origin 
have been described by Putrino et al. (13) and 
Reis-Filho et al. (14). PEH originating from eccrine 
duct epithelia has been described by Hanly et al. 
(15).  
 Mott et al. collected the largest reported series 
of 13 cases of PEH in association with melanoma. 
Seven cases of described PEH overlying mela-
noma originated from the epidermis, five cases 
arose directly from follicular epithelium, and one 
from eccrine epithelium (16). The majority of cas-
es (69%) exhibited acanthosis, hyperkeratosis, 
papillomatosis, and irregular infiltrating epithe-
lial cords with squamous eddies. The remaining 
cases (31%) demonstrated basaloid acantho-
sis, laminated orthokeratosis and horn cysts. 
Several reports have documented melanoma in 
conjunction with, or simulating seborrheic kerato-
sis. While most cases represent a collision of the 
two entities, some authors suggest the possibil-
ity that epidermal changes resembling seborrheic 
keratosis within the confines of the melanoma 
could be an induced phenomenon (17,18).  
 The mechanism of PEH is unknown. Some 
theories speculate that the histogenesis of PEH 
is due to the proliferative effect of cytokines re-
leased by inflammatory or tumor cells within the 
subjacent dermis. Epidermal proliferation is co-
ordinated by a variety of mediators including epi-
dermal growth factor (EGF), transforming growth 
factor α (TGF-α) and epidermal growth factor re-
ceptor (EGFR), and it is postulated that dysregu-
lation of these growth factors may be important in 
the development of PEH (19,20). Among the three 
growth factors mentioned in literature reports, only 
TGF-α appears to be related to the development 
of PEH (21,22). Other peptide growth factors such 
as fibroblastic growth factor and platelet-derived 
growth factor may be important for exuberant epi-
thelial proliferation in PEH. The reason for PEH 
development in the absence of growth factors is 
still unknown. 
 Expression of p53 in the skin is common and 
is an early event indicating immaturity and pro-
liferative capacity of the keratinocytic cell. This 
expression of p53 need not necessarily indicate 
neoplastic or malignant transformation. Lee and 
The observed positive staining for p53 in six cas-
es of PEH of the skin (20). The bcl-2 protein sup-
presses apoptosis and overexpression of the bcl-2 
protein has been reported in malignant melanoma 
of the skin (21). Results of our analyses of p53 
and bcl-2 protein expression suggested a differ-
ence in the proliferating capacity of infiltrating epi-
thelial strands compared with horn cysts. p53 was 
expressed mainly in the cells at the base of the 
Figure 2. Expression of p53 (A) and bcl-2 (B) in infiltrating keratinocytic cells and horn cysts in the dermis. 
(A and B, x400)
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epidermis. Moderate intensity staining was ob-
served in basal cells of the infiltrating strands and 
overlying epidermis, and week staining in basal 
cells of horn cysts. Infiltrating strands of the epi-
thelium, basal and parabasal cells of the hyper-
plastic epithelium compared with horn cysts also 
expressed stronger positivity for bcl-2 protein. It 
is possible that dysregulation of members of the 
bcl-2 protein family could play a role in the patho-
genesis of PEH. Additional studies are necessary 
to identify the possible cause and prognostic impli-
cations for this variant of skin melanomas. 
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